Exploratory Study of Norepinephrine to Prevent Radiodermatitis in Breast Cancer Patients
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Radiodermatitis
Interventions: DRUG: Norepinephrine
Sponsor: ProCertus BioPharm, Inc
Collaborators: University of Wisconsin, Madison